MacroGenics
MGNX
#8653
Rank
C$0.33 B
Marketcap
C$5.21
Share price
-7.73%
Change (1 day)
127.77%
Change (1 year)

MacroGenics (MGNX) - Cash on Hand

Cash on Hand as of March 2026 : C$0.21 Billion

According to MacroGenics's latest financial reports the company has C$0.21 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

MacroGenics - Cash on Hand chart (from 2012 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31C$0.26 B-10.13%
2024-12-31C$0.28 B-5.06%
2023-12-31C$0.30 B45.53%
2022-12-31C$0.20 B-32.54%
2021-12-31C$0.31 B-10.65%
2020-12-31C$0.34 B23.32%
2019-12-31C$0.28 B-11.16%
2018-12-31C$0.31 B-17.31%
2017-12-31C$0.38 B3.06%
2016-12-31C$0.37 B-20.86%
2015-12-31C$0.47 B157.18%
2014-12-31C$0.18 B47.49%
2013-12-31C$0.12 B161.17%
2012-12-31C$47.47 M-15.48%
2011-12-31C$56.16 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Pfizer
PFE
C$18.41 B 8,377.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$7.44 B 3,324.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$16.95 B 7,705.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.76 B 4,855.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$8.03 B 3,597.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$14.77 B 6,698.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
C$0.62 B 188.50%๐Ÿ‡บ๐Ÿ‡ธ USA